Search

Researchers at Henan University of Urban Construction in China have reported new findings on the role of copper complexes with quinoline-thiosemicarbazone hybrid ligands in promoting apoptosis by causing DNA and mitochondria dual lesions. The study synthesized and characterized two copper complexes derived from bioactive conjugates and found that they exhibited effective anti-proliferative activity against malignant tumor cells, particularly complex 1. Mechanistic studies revealed that complex 1 could enter cells, block the cell cycle, induce mitochondrial dysfunction, and trigger cell death via apoptosis. The research, funded by various sources, concluded that complex 1 bound to CT-DNA and efficiently cleaved DNA in the presence of H2O2. [Extracted from the article]

A new report from researchers at the University of Silesia in Poland explores the role of iron in phototherapy. The study investigates the impact of 5-aminolevulinic acid (ALA) in combination with iron chelators on iron metabolism and the efficacy of ALA-photodynamic therapy (PDT). The researchers observed differences in gene expression depending on the cell line studied, and they identified versatile and effective compounds with potential for use in ALA-PDT. This research provides valuable insights into the relationship between iron metabolism and phototherapy. [Extracted from the article]

A report from the University of the Republic in Montevideo, Uruguay discusses research on Chagas disease, a neglected tropical disease caused by the parasite Trypanosoma cruzi. The researchers designed and synthesized eight novel palladium and platinum complexes containing bioactive ligands for potential use as drugs for the treatment of Chagas disease. The compounds were tested for their activity against T. cruzi and their cytotoxicity on mammalian cell lines. The results showed that the palladium complexes improved the ligands' anti-T. cruzi activity but also had cytotoxic effects. Further studies are needed to optimize the design of new compounds with less toxicity and higher anti-T. cruzi activity. [Extracted from the article]

A report from the Chemistry and Chemical Engineering Research Center of Iran discusses the synthesis and characterization of a new nickel(II) coordination complex that could have potential applications in cancer therapy. The complex, called [NiL], was evaluated for its anticancer activity against a human breast cancer cell line and compared to standard anticancer drugs. The researchers also conducted density functional theory calculations and docking simulations to understand the chemical reactivity and DNA binding properties of the complex. This research provides new insights into the development of novel cancer therapies. [Extracted from the article]

Researchers from the University of Queensland in Brisbane, Australia have made a significant discovery in the field of theranostics. They have developed a chelator called H2DOTS that forms stable complexes with the alpha-emitting radionuclides Bismuth-212 and Lead-212. The chelator demonstrated efficient complexation and remarkable kinetic inertness, making it a promising candidate for the development of theranostic radiopharmaceuticals. The research has been peer-reviewed and provides valuable insights into the potential applications of this new chelator. [Extracted from the article]

A recent study conducted by researchers at Tribhuvan University in Kathmandu, Nepal, has provided new insights into anticancer agents. The researchers synthesized and characterized thiosemicarbazones and Schiff's bases, and evaluated their anticancer potency against the human breast cancer cell line (MCF-7). The compounds exhibited good to moderate anticancer efficacy, with the most potent compound showing significant cytotoxicity. Molecular docking and DFT calculations demonstrated the compounds' binding affinity and interactions with target proteins. The study concluded that the synthesized compounds have drug-like action and high efficacy towards target enzymes. [Extracted from the article]

A recent study conducted at Bahauddin Zakariya University in Multan, Pakistan, has focused on the development of potential treatments for neurodegenerative diseases and conditions. The researchers investigated a series of indole-based thiosemicarbazones as inhibitors of prolyl oligopeptidase (POP), an enzyme that is highly expressed in the brain and is associated with various central nervous system illnesses. The compounds tested in the study showed significant inhibition of POP in vitro at low doses, with one compound, 3g, displaying the highest inhibition. The research utilized various analytical techniques to confirm the structures of the compounds and also performed molecular docking studies to understand their binding modes. This research has been peer-reviewed and may provide valuable insights for the development of new treatments for neurodegenerative diseases. [Extracted from the article]

Researchers from Abdul Wali Khan University in Mardan, Pakistan have conducted a study on the anti-diabetic potential of thiosemicarbazone derivatives. The researchers synthesized these derivatives and tested their inhibitory activities against alpha-glucosidase and alpha-amylase enzymes. Six compounds showed high alpha-glucosidase activity, while five compounds exhibited excellent inhibitory activity against alpha-amylase. The study also included density functional theory (DFT) and molecular docking analysis to understand the compounds' interactions with the enzymes. These findings have potential implications for the development of therapeutic candidates to regulate postprandial glucose levels in diabetic patients. [Extracted from the article]

The article focuses on research from the University of Parma investigating the transient adaptation of Toxoplasma gondii to thiosemicarbazone drugs targeting ribosomal proteins. Topics include the effects of these drugs on parasite proliferation and structure, the identification of proteins interacting with the drugs, and the development of drug tolerance in T. gondii associated with upregulated expression of ribosomal and transmembrane proteins.

Researchers from Soochow University in Suzhou, China have synthesized a new thiosemicarbazone-based drug with a thiazole spectator for efficient coordination with copper (II). The drug, called H L, demonstrated dimeric structures and exhibited dual functions of chelation and intermolecular bridging. It showed high toxicity against hepatocellular carcinoma cell lines and was found to be effective in inhibiting cancer cell proliferation. Preliminary pharmacokinetic studies also showed that H L has promising oral bioavailability, making it a potential chemotherapeutic drug. [Extracted from the article]

A recent study conducted by researchers at the Federal University of Vale do Sao Francisco in Brazil explores the potential of thiosemicarbazones as leishmanicidal agents. Thiosemicarbazones are organic compounds known for their biological properties and are considered important for drug development. The researchers conducted a systematic review of publications from the past decade and identified 118 thiosemicarbazones that were synthesized and tested in vitro for their activity against Leishmania protozoa. The study concludes that thiosemicarbazones show significant leishmanicidal activity and represent a promising area of research. [Extracted from the article]

Researchers at Jadavpur University in Kolkata, India have reported the fabrication of new thiosemicarbazone-based Pd(ii) complexes that have potential applications as catalysts and chemotherapeutic drugs. The complexes were characterized using spectroscopic techniques and their structures were determined using X-ray diffraction methods. The complexes showed good biomolecular interactions with DNA/protein and demonstrated antitumor activity against triple-negative breast cancer cells. The research concluded that the complexes induced apoptosis through a mitochondria-dependent pathway. This study provides valuable insights into the development of new cancer therapies. [Extracted from the article]

A study conducted at the Indian Institute of Technology (IIT) Indore in India has published findings on the synthesis and characterization of six new ruthenium complexes with phenolic acid ligands. The complexes were evaluated for their cytotoxicity and cell migration abilities, and three of them were found to be selectively cytotoxic towards melanoma cell lines while being non-cytotoxic towards non-cancerous cell lines. The study also investigated the bio-molecular interaction mechanisms of the complexes, revealing strong interactions with DNA and proteins. Additionally, staining techniques and protein expression studies confirmed that the complexes induce cell death through apoptosis. The research was supported by various funding organizations. [Extracted from the article]

Researchers from Henan University in China have developed an injectable hydrogel loaded with antibacterial compounds called thiosemicarbazones. The hydrogel demonstrated excellent self-healing properties and effectively treated wounds by completely covering them. It also showed strong antibacterial activity against various types of bacteria, including drug-resistant strains. The hydrogel was found to be compatible with cells and enhanced wound healing in mice. This research expands the possibilities for designing antibacterial wound dressings. [Extracted from the article]

A recent study conducted by researchers at the University of Paris Saclay in Versailles, France, has investigated the synthesis, structure, and biological properties of a series of dicopper(bis-thiosemicarbazone) complexes. The researchers synthesized fifteen new coordination binuclear compounds of copper(ii) using substituted 4-tert-butyl-2,6-bis(N4-thiosemicarbazonyl)phenol ditopic ligands. The complexes were characterized and found to exhibit antioxidant, antimicrobial, and antifungal activities, with properties comparable to commonly used drugs in this field. The study highlights the potential of these complexes as anti-infective agents. [Extracted from the article]

A recent study conducted at the National Institute of Technology Patna in Bihar, India, has reported new findings on the synthesis and characterization of nickel(II) and palladium(II) complexes with an imine-based tridentate ligand. The researchers used various spectroscopic methods to analyze the compounds, including NMR, FT-IR, HRMS, and UV-Vis spectroscopy. The complexes showed promising antimicrobial activity against bacterial and fungal strains, with the nickel(II) complex exhibiting stronger anti-cancer properties compared to the palladium(II) complex. The study suggests that these complexes have the potential to be developed as therapeutic agents for antimicrobial and anticancer treatments. [Extracted from the article]

A recent study conducted at Federal University Sao Carlos in Brazil focused on the synthesis and characterization of new palladium and nickel complexes containing thiosemicarbazone ligands. The compounds were fully characterized using various techniques, and crystallography analysis was successful for some of them. While the compounds did not show any interaction with DNA or inhibition of topoisomerase II alpha enzyme activity, they exhibited potent cytotoxic effects against breast tumor and prostate cell lines. The study highlights the importance of structural variations and the nature of the metallic center in developing bioactive compounds. [Extracted from the article]

A recent study conducted at Mody University of Science and Technology in Rajasthan, India, focused on the synthesis and characterization of new compounds derived from symmetrical chalcones. The researchers used various spectroscopic techniques to describe the newly synthesized compounds and evaluated their antibacterial properties against Bacillus subtilis and Escherichia coli. Molecular docking and in silico analysis were also performed to determine the compounds' binding affinity and drug-likeness properties. The study found that the synthesized molecules showed promising antibacterial activity and exhibited favorable drug-like properties. [Extracted from the article]

A recent study conducted by researchers at COMSATS University Islamabad in Abbottabad, Pakistan, has found that certain compounds called 2-chloroquinoline-3-carbaldehyd thiosemicarbazone derivatives show promise in treating neurodegenerative diseases like Alzheimer's. These compounds were found to be effective against enzymes associated with cognitive decline, such as monoamine oxidases (MAOs) and cholinesterases (AChE and BChE). The study used in vitro testing, density functional theory (DFT), molecular docking studies, and molecular dynamic (MD) simulations to evaluate the compounds' efficacy. Compound 3g was identified as a particularly promising multi-targeted compound for Alzheimer's treatment. [Extracted from the article]

A study conducted at Guilin Medical University in China has found that two thiosemicarbazone-copper complexes show promising anticancer activity against lung adenocarcinoma cells. These complexes were found to be more effective than cisplatin, a commonly used chemotherapy drug, and exhibited low systemic toxicity. The researchers concluded that one of the complexes, known as complex 2, is the first mixed-valent Cu(I/II) complex to induce cellular events consistent with cuproptosis in cancer cells, which may have implications for the development of effective cancer therapies. This research was supported by the National Natural Science Foundation of China. [Extracted from the article]

Researchers from Kinnaird College for Women in Lahore, Pakistan have made advances in the treatment of ureolytic bacterial infections by targeting the urease enzyme. They designed and synthesized morpholine-thiophene hybrid thiosemicarbazone derivatives and evaluated their potential to inhibit urease enzyme in vitro. The majority of the synthesized compounds were more potent than the conventional inhibitor, thiourea. The lead inhibitor, 2-(1-(5-chlorothiophen-2-yl)ethylidene)-N-(2-morpholinoethyl)hydrazinecarbothioamide, showed strong affinity for the urease active site and displayed druglikeness behavior. This research provides insights into potential treatments for bacterial infections. [Extracted from the article]

A recent study conducted by researchers at the University of Atacama in Copiapo, Chile, explored the effects of different coordination modes of thiosemicarbazone ligands on the biological activities of Ru(II)-benzene complexes. The complexes were characterized using single crystal X-ray diffraction, revealing a piano-stool geometry around the Ru(II) ion. The binding capabilities of the complexes towards CT DNA and BSA were evaluated, and cytotoxicity assays showed promising activity against cancer cells. The mode of cell death was determined to be apoptosis, mediated by the ROS-mediated mitochondrial signaling pathway. This research provides valuable insights into potential anticancer agents. [Extracted from the article]

A recent report from Manipal University in Jaipur, India discusses the investigation of organotin (IV) thiosemicarbazones as precursors for synthesizing nanoscaled tin tulfide materials. The researchers formed a sequence of compounds through reactions of R2SnCl2 with ligands LH, and characterized them using various techniques including FT-IR, NMR, and mass studies. The researchers also conducted thermogravimetric analysis and solvothermal techniques to transform the compounds into tin sulfides. The resulting tin sulfides exhibited plate-like morphologies and an orthorhombic structure. This research has been peer-reviewed and published in the Journal of Materials Science Materials in Electronics. [Extracted from the article]

Researchers at the University of Guilan in Rasht, Iran have conducted a study on the synthesis of biocompatible copper oxide nanoparticles functionalized with thiosemicarbazone. The nanoparticles were prepared using a sonochemical method and characterized using various techniques. The study found that the synthesized nanoparticles exhibited enhanced antibacterial activity against both Gram-positive and Gram-negative bacterial strains. The results suggest that these nanoparticles could be used in the development of more effective antibacterial materials for pharmaceutical applications. [Extracted from the article]

A new study conducted by researchers at the Islamic University of Madinah in Saudi Arabia focuses on the development of antimicrobial agents to combat antibiotic resistance. The researchers synthesized bis-thiazole compounds and evaluated their antimicrobial efficacy. Molecular docking studies were also conducted to understand the interaction mechanisms of the compounds with the target protein. The results showed promising antimicrobial properties and a favorable pharmacokinetic and pharmacodynamic profile for the compounds. This research contributes to international efforts in addressing the global threat of infections and the need for innovative therapeutic approaches. [Extracted from the article]

Researchers at Guangxi Normal University in the People's Republic of China have developed a copper compound based on human serum albumin (HSA) and indomethacin (IND) to remodel the tumor microenvironment (TME) and enhance antitumor efficacy. The compound, known as C4, showed significant cytotoxicity and was delivered through an HSA-IND-C4 complex. In vivo studies demonstrated improved targeting ability, decreased side effects, and enhanced antitumor efficacy compared to C4 and C4 + IND. The mechanism of action involved inhibiting tumor-related inflammation, inducing apoptosis and autophagy of cancer cells, and inhibiting tumor angiogenesis. This research has been peer-reviewed and published in the Journal of Medicinal Chemistry. [Extracted from the article]

A study conducted at the University of Burdwan in India has reported on the synthesis and characterization of three Ni(II) complexes of thiosemicarbazone ligand. The complexes were found to have anti-cancer and anti-angiogenic activities, inhibiting the growth of cancer cells and blood vessels. The research suggests that these complexes could be effective in retarding and inhibiting tumor growth and progression. The study was supported by the Department of Atomic Energy (DAE) and has been peer-reviewed. [Extracted from the article]

A recent study conducted at the Universidad Autonoma de Madrid in Spain has focused on the development of new chemotherapeutic agents with low toxicity and high selectivity. The researchers synthesized and characterized a hybrid thiosemicarbazone/hydrazone ligand and several complexes with tin and organotin. These compounds were evaluated for their antiproliferative activity against various cancer cell lines and normal cells, and they exhibited higher activity than cisplatin, a commonly used chemotherapy drug. The most active complex induced apoptotic cell death in a triple negative breast cancer cell line by generating reactive oxygen species and disrupting mitochondrial membrane potential. [Extracted from the article]

A recent report from Guangxi Normal University in China discusses the development of a potential metal agent to reverse the resistance of cancer cells to cisplatin and inhibit tumor growth and metastasis. The researchers designed and synthesized a cyclometalated iridium complex that showed remarkable fluorescence and cytotoxicity to cancer cells. The complex not only targeted mitochondria but also overcame cisplatin resistance and effectively inhibited tumor growth and metastasis in vivo. The researchers also confirmed the complex's anticancer mechanisms, including inducing necroptosis and activating the necroptosis-related immune response. This research has been peer-reviewed and published in the Journal of Medicinal Chemistry. [Extracted from the article]

Researchers from Ain Shams University in Cairo, Egypt have conducted a study on novel thiosemicarbazone complexes as anticancer agents. The researchers synthesized Co (II), Ni (II), and Cu (II) complexes based on rho-dimethylaminobenzaldehyde thiosemicarbazone (DABT) as chelating agents. The structures of the complexes were determined through various analyses, and their antitumor activity was examined against hepatocellular carcinoma cell lines. The DABT-Ni (II) complex showed the highest antitumor activity and was found to be effective as a topoisomerase inhibitor. The study confirmed the theoretical data through experimental studies. [Extracted from the article]

New research from Punjab Engineering College in Chandigarh, India, explores the potential of rhenium complexes as novel antimicrobial agents. The study synthesized and characterized three rhenium carbonyl thiosemicarbazone (TSC) complexes and evaluated their antibacterial activity against gram-positive and gram-negative bacteria. The results showed that the synthesized complexes were ineffective against gram-negative bacteria but exhibited excellent antibacterial activity against gram-positive bacteria, particularly S.aureus. In-silico molecular docking studies also demonstrated the potential of these complexes in the development of new antibacterial drugs. The research suggests a possible synergistic effect between the metal center and the organic ligand in enhancing the antibacterial properties of the complexes. [Extracted from the article]

A research study conducted at Aydin Adnan Menderes University explored the larvicidal activity of aromatic thiosemicarbazone-oxime derivatives and their metal complexes (Ni(II), Cu(II), and Co(II)) against Aedes aegypti and Aedes albopictus larvae. The study found that both TP1 and TP2 compounds, as well as their Co(II) complexes, demonstrated high efficacy against the larvae. The researchers concluded that the C=S groups in thiosemicarbazone derivatives are effective in showing activity, suggesting that further studies should be conducted to enhance the effectiveness of these components. The full research article can be accessed for free through the provided link. [Extracted from the article]

A recent study conducted in Liaoning, People's Republic of China, has explored the potential of Pt(II) and Pd(II) complexes as anticancer drugs. The researchers synthesized two trapezoid planar structures using 2-phenyl-1H-imidazo[4,5-f][1,10]phenanthroline as a ligand. The complexes were characterized and found to interact with ct-DNA and induce apoptosis in HeLa cells. Complex 1 showed particularly promising results, with a significantly higher number of apoptotic cells compared to the control group. This research suggests that these complexes have potential as candidates for inducing apoptosis in cancer cells. [Extracted from the article]

A recent report from the Hanoi National University of Education in Vietnam discusses new research on cancer treatment. The researchers successfully synthesized a new derivative called 5,7-dichloro-8-hydroxyquinoline-2-carboxaldehyde-4-phenyl-3-thiosemicarbazone (QPS) and seven complexes of QPS with transition metals. Spectrometry methods were used to determine the structure of the complexes, and it was found that most of them had a metal:ligand ratio of 1:1. Some of the complexes showed medium inhibition to cancer cell lines, while others had high activity against certain types of cancer cells. The research concluded that one of the complexes, CdQPS, showed excellent activity against cancer cells. This research has been peer-reviewed and more information can be obtained from the Hanoi National University of Education. [Extracted from the article]

A study conducted by researchers at Islamic Azad University in Rasht, Iran, has found that combining thymol and zinc oxide nanoparticles conjugated with thiosemicarbazone can effectively inhibit biofilm formation and combat Pseudomonas aeruginosa infections. Biofilms, which are communities of bacteria, are often more resistant to antimicrobials than individual bacteria. The researchers synthesized and characterized the nanoparticles, and their experiments showed that the combination of thymol and the nanoparticles had a stronger antibacterial and antibiofilm effect compared to either agent alone. Further research is needed to explore the potential of this combination for treating P. aeruginosa infections. [Extracted from the article]

Researchers at Federal University Juiz De Fora in Brazil have synthesized six copper(II) coordination complexes containing azole drugs with antifungal and antiparasitic properties. The complexes were characterized using various analytical and spectroscopic techniques, and their stability was validated through spectrophotometric measurements. In vitro analysis showed promising anti-leishmanial and anti-Sporothrix activity for some of the investigated systems. This research provides new insights into the potential use of these hybrid copper(II) complexes as anti-infective agents. [Extracted from the article]

A research study conducted at Bahauddin Zakariya University in Multan, Pakistan, has synthesized and characterized a series of bioactive compounds called 1,3-Thiazoles. These compounds were evaluated for their antibacterial and antioxidant properties, and several showed potential as antibacterial agents and antioxidants. Molecular docking studies also revealed that two compounds displayed strong activity against GlcN-6-P synthase. The researchers suggest that these compounds have potential for further investigation and development by researchers and pharmaceutical companies. [Extracted from the article]

A recent study conducted by researchers at the University of Parma in Italy explores the potential medicinal applications of coordination compounds containing gallium and indium. These metals are combined with thiosemicarbazones, ligating compounds known for their biological and pharmaceutical applications. The researchers synthesized and characterized these compounds, finding stable formations with a 2:1 ligand-to-metal stoichiometry. However, further investigation revealed that these compounds are more suitable for radio imaging applications rather than for antitumoral or antimicrobic purposes. [Extracted from the article]

A report from Xiamen University in Fujian, China discusses research on liver fibrosis, a global health challenge with limited treatment options. The study focuses on the orphan nuclear receptor Nur77 and its role in regulating autophagy and liver fibrosis. The researchers synthesized four types of Nur77-based thiourea derivatives and found that one compound, 9e, was the most effective inhibitor of hepatic stellate cells (HSCs) proliferation and activation. In vivo experiments showed that 9e reduced hepatic inflammation and extracellular matrix production, suggesting it could be a promising candidate for treating chronic liver fibrosis. The research has been peer-reviewed and published in Bioorganic Chemistry. [Extracted from the article]

A study conducted at Sharda University in Greater Noida, India, focused on the potential cytotoxicity of a chemical molecule called 4-nitro acetophenone thiosemicarbazone (4-NAPTSc) against lung cancer cell lines. The compound was synthesized and characterized, and its cytotoxicity was evaluated using a cell viability assay. Molecular docking studies showed that the compound binds to specific proteins involved in cancer growth. The researchers concluded that 4-NAPTSc has potential for further investigation and could be used in multitargeted cancer therapies. This research has been peer-reviewed and published in Applied Biochemistry and Biotechnology. [Extracted from the article]

Researchers at Sultan Qaboos University in Muscat, Oman have discovered new data on cancer. They have developed copper(II) thiosemicarbazone complexes that exhibit marked selective antiproliferative activity against cancer cells. The complexes were found to outperform cisplatin, a commonly used chemotherapy drug, in terms of potency and selectivity towards HeLa and MCF-7 cancer cell lines. This research provides valuable insights into potential new treatments for cancer. [Extracted from the article]

Researchers at the University of Sydney in Australia have conducted a study on the anti-cancer properties of a compound called di-2-pyridylthiosemicarbazone (DpT). They synthesized and characterized various complexes of DpT with different metals, including Fe, Co, Ni, Cu, Zn, Ga, and Pd. The study found that the complexes displayed distinct biological activity, with some showing potent anti-proliferative effects against cancer cells. The researchers also observed differences in transmetallation, or the exchange of metals, between the complexes, which affected their efficacy and off-target effects. This research provides valuable insights into the mechanism of action and potential therapeutic applications of these DpT complexes as anti-cancer agents. [Extracted from the article]

A study conducted by researchers at Islamic Azad University in Rasht, Iran, has investigated the use of ZnO nanoparticles and thymol in inhibiting the expression of biofilm and efflux pump genes in Pseudomonas aeruginosa. The researchers synthesized ZnO nanoparticles functionalized by Thiosemicarbazone nanoparticles and found that the combination of ZnO@Glu-TSC and thymol had a stronger inhibitory effect on P. aeruginosa than either agent alone. The study suggests that ZnO@Glu-TSC NPs and thymol could be a potential antibacterial treatment for P. aeruginosa strains. Further research is needed to explore the effectiveness of this combination. [Extracted from the article]